The production of 5 new reduced glutathione enteric coated capsules and 6 generic adenosylmethionine succinate for injection in Shuanglu pharmaceutical industry was accepted

According to the public information, reduced glutathione enteric coated capsules have been used for injection, tablet and eye drops in China, and there is no enteric coated capsule formulation In addition to Shuanglu pharmaceutical industry, Shandong LVYE Pharmaceutical Co., Ltd is also applying for the production of the dosage form Reduced glutathione (GSH) is a kind of peptide naturally synthesized in human cytoplasm, which is suitable for detoxification of drugs (anti-tumor drugs, anti tuberculosis drugs, central nervous drugs, paracetamol and other poisons), prevention of side effects of anti-cancer drugs, etc its raw material glutathione has two pharmaceutical enterprises, namely Haizheng Pharmaceutical (600267 SH) and Jincheng Pharmaceutical (300233 SZ) In addition, ademetionine succinate for injection was developed by hospitra S.p.A., an Italian pharmaceutical company At present, only Haizheng pharmaceutical and Zhejiang Zhenyuan (000705 SZ) are producing ademetionine for injection in domestic pharmaceutical companies The drug is suitable for pre cirrhosis and intrahepatic cholestasis caused by cirrhosis According to the data published by Zhongjing, the original research drug (trade name "simitai") entered the medical insurance for the first time in 2009, and the amount of drugs purchased by the hospital reached 230 million yuan in 2010, with a large market space.